1/13
08:01 am
tem
Tempus AI (TEM) Soars 15% on $1.1-Billion Deal [Yahoo! Finance]
Medium
Report
Tempus AI (TEM) Soars 15% on $1.1-Billion Deal [Yahoo! Finance]
1/12
08:30 am
tem
Tempus and NYU Langone Health Announce Strategic Collaboration to Advance Precision Oncology
Medium
Report
Tempus and NYU Langone Health Announce Strategic Collaboration to Advance Precision Oncology
1/12
07:00 am
tem
Northwestern Medicine Selects Tempus to Expand Genomic Testing
Medium
Report
Northwestern Medicine Selects Tempus to Expand Genomic Testing
1/11
05:37 pm
tem
Tempus Achieves Record Total Contract Value Exceeding $1.1 Billion [Yahoo! Finance]
Medium
Report
Tempus Achieves Record Total Contract Value Exceeding $1.1 Billion [Yahoo! Finance]
1/11
05:30 pm
tem
Tempus Achieves Record Total Contract Value Exceeding $1.1 Billion
Medium
Report
Tempus Achieves Record Total Contract Value Exceeding $1.1 Billion
1/11
05:00 pm
tem
Tempus Announces Preliminary Fourth Quarter and Full Year 2025 Results
Medium
Report
Tempus Announces Preliminary Fourth Quarter and Full Year 2025 Results
1/8
08:30 am
tem
Tempus Announces Eight Abstracts Accepted for Presentation at the 2026 ASCO® Gastrointestinal Cancers Symposium
Low
Report
Tempus Announces Eight Abstracts Accepted for Presentation at the 2026 ASCO® Gastrointestinal Cancers Symposium
1/6
08:30 am
tem
Tempus to Present at 44th Annual J.P. Morgan Healthcare Conference
Medium
Report
Tempus to Present at 44th Annual J.P. Morgan Healthcare Conference
1/2
09:22 am
tem
TD Cowen Reaffirms Hold Rating on Tempus AI (TEM), Cites the Company's Position to be a Leader [Yahoo! Finance]
Medium
Report
TD Cowen Reaffirms Hold Rating on Tempus AI (TEM), Cites the Company's Position to be a Leader [Yahoo! Finance]
1/1
07:22 am
tem
Canaccord Lowers Price Objective On Tempus AI, Inc. (TEM) [Yahoo! Finance]
Medium
Report
Canaccord Lowers Price Objective On Tempus AI, Inc. (TEM) [Yahoo! Finance]
12/22
10:37 pm
tem
BofA and JPMorgan Lower Tempus AI, Inc. (TEM) Price Targets on Valuation Concerns [Yahoo! Finance]
Low
Report
BofA and JPMorgan Lower Tempus AI, Inc. (TEM) Price Targets on Valuation Concerns [Yahoo! Finance]
12/22
08:02 am
tem
Tempus AI (NASDAQ:TEM) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $95.00 to $80.00. They now have a "buy" rating on the stock.
Low
Report
Tempus AI (NASDAQ:TEM) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $95.00 to $80.00. They now have a "buy" rating on the stock.
12/16
07:06 pm
tem
Tempus AI Revenue Jumps 85% as Pricing Catalysts Line Up [Yahoo! Finance]
Medium
Report
Tempus AI Revenue Jumps 85% as Pricing Catalysts Line Up [Yahoo! Finance]
12/15
02:24 pm
tem
Tempus AI (NASDAQ:TEM) had its price target lowered by analysts at JPMorgan Chase & Co. from $85.00 to $80.00. They now have a "neutral" rating on the stock.
Low
Report
Tempus AI (NASDAQ:TEM) had its price target lowered by analysts at JPMorgan Chase & Co. from $85.00 to $80.00. They now have a "neutral" rating on the stock.
12/15
07:46 am
tem
Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now? [Yahoo! Finance]
Medium
Report
Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now? [Yahoo! Finance]
12/9
08:30 am
tem
Tempus Announces Ten Abstracts Accepted for Presentation at the 2025 San Antonio Breast Cancer Symposium
Low
Report
Tempus Announces Ten Abstracts Accepted for Presentation at the 2025 San Antonio Breast Cancer Symposium
12/4
10:58 am
tem
Tempus AI, Inc. (TEM): A Bull Case Theory [Yahoo! Finance]
Low
Report
Tempus AI, Inc. (TEM): A Bull Case Theory [Yahoo! Finance]
12/1
06:03 pm
tem
Tempus AI (NASDAQ:TEM) was given a new $85.00 price target on by analysts at Morgan Stanley.
Low
Report
Tempus AI (NASDAQ:TEM) was given a new $85.00 price target on by analysts at Morgan Stanley.
12/1
05:37 am
tem
Cathie Wood's Health Tech Bet: Why Analysts See Long-Term Upside in Tempus AI (TEM) [Yahoo! Finance]
Medium
Report
Cathie Wood's Health Tech Bet: Why Analysts See Long-Term Upside in Tempus AI (TEM) [Yahoo! Finance]
11/25
07:19 am
tem
Tempus AI (NASDAQ:TEM) had its "buy" rating reaffirmed by analysts at BTIG Research.
Low
Report
Tempus AI (NASDAQ:TEM) had its "buy" rating reaffirmed by analysts at BTIG Research.
11/18
08:30 am
tem
Tempus to Participate in the Piper Sandler 37th Annual Healthcare Conference
Low
Report
Tempus to Participate in the Piper Sandler 37th Annual Healthcare Conference
11/15
11:51 pm
tem
Tempus AI Retains Buy Rating as Canaccord Adjusts Price Target to $95 After Q3 Beat [Yahoo! Finance]
Medium
Report
Tempus AI Retains Buy Rating as Canaccord Adjusts Price Target to $95 After Q3 Beat [Yahoo! Finance]
11/15
10:01 am
tem
Tempus AI: Opportunity To Build Position [Seeking Alpha]
Medium
Report
Tempus AI: Opportunity To Build Position [Seeking Alpha]
11/14
08:48 am
tem
Tempus and IFLI Announce Study to Advance Follicular Lymphoma Research [Yahoo! Finance]
Low
Report
Tempus and IFLI Announce Study to Advance Follicular Lymphoma Research [Yahoo! Finance]
11/14
08:30 am
tem
Tempus and IFLI Announce Study to Advance Follicular Lymphoma Research
Medium
Report
Tempus and IFLI Announce Study to Advance Follicular Lymphoma Research